Michael Pursley, MD
Cardiology · Fairhope, ALNPI 1467430777
Payments from drug & device makers
Across 973 payments — averaging $1600.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$492K
- AstraZeneca$447K
- Amgen$165K
- Bayer$154K
- Pfizer$142K
- Novo Nordisk AS$138K
- plus $19K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 31 | $491,786 |
| AstraZeneca | 31 | $447,478 |
| Amgen | 30 | $165,460 |
| Bayer | 53 | $154,024 |
| Pfizer | 59 | $141,893 |
| Novo Nordisk AS | 609 | $138,248 |
| Boehringer Ingelheim | 12 | $8,204 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $6,677 |
| Merck | 34 | $626 |
| E.r. Squibb & Sons, L.L.C. | 26 | $531 |
| Johnson & Johnson | 32 | $489 |
| Welch Allyn | 1 | $426 |
| Boehringer Ingelheim International GmbH | 9 | $420 |
| Boston Scientific | 9 | $329 |
| Sanofi-aventis U.S. LLC | 8 | $222 |
| Novo Nordisk | 6 | $137 |
| Alnylam Pharmaceuticals Inc. | 2 | $72 |
| Abbott | 2 | $67 |
| Esperion Therapeutics, Inc. | 4 | $62 |
| Irhythm Technologies, Inc. | 2 | $58 |
| Baxter Healthcare | 1 | $37 |
| Edwards Lifesciences | 1 | $36 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $34 |
| Atricure, Inc. | 1 | $28 |
| Philips North America LLC | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| GSK | 1 | $25 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Cardiovascular Systems Inc. | 1 | $16 |
How this compares
Too few cardiology providers in Alabamato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiology in Fairhope
- Glenn HarrisFairhope$3K
- Osita OnyekwereAnniston$193K
- John NeillBirmingham$14K
- Sharon DaileyBirmingham$0
- Gilbert PerryBirmingham$0
- Ferdinand UrthalerBirmingham$0
- Richard ChernickMobile$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.